A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.
Clinical trial NCT06244316 · COMPLETED
Trial details
- NCT number
- NCT06244316
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-22
- Primary completion
- 2024-12-04
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.